METHOD FOR PRODUCING AND VACCINE COMPOSITION OF NEISSERIA MENINGITIDIS SEROGROUPS A, C, Y, AND W-135 OLIGOSACCHARIDES CONJUGATED TO GLYCAN-FREE CARRIER PROTEIN
A multivalent vaccine composition, a method of producing the multivalent vaccine composition, and an apparatus containing the multivalent vaccine composition. The multivalent vaccine composition may include a mixture. The mixture may include Neisseria meningitides serogroups A, C, Y, and W-135 oligosaccharides conjugated to glycan-free carrier proteins. When administered, the multivalent vaccine composition may provide long-lasting immunity to humans of all age groups, including infants.
